Extinction session schedule was just like the acquisition program, except for the absence of any delivery of JWH-018 infusion. Just after six periods carried out in extinction phase, the protocol was switched to reacquisition section for 7 sessions in the same condition of acquisition.On 24th November 2010 the Federal Drugs Enforcement Agency (DEA)